Rathi N. Pillai
- Oncology top 0.5%
- Lung Cancer Research Studies 29
- Cancer Immunotherapy and Biomarkers 24
- CAR-T cell therapy research 7
- Immunology top 2%
-
- Lung Cancer Treatments and Mutations 42
- Lung Cancer Diagnosis and Treatment 26
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 6
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 6
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- Suresh S. RamalingamTaofeek K. OwonikokoAlice O. KamphorstRafi AhmedFadlo R. KhuriMadhusmita BeheraGabriel SicaKoichi Araki
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Rathi N. Pillai
84 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 3.0k
- Immunology 1.5k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 357
- Otorhinolaryngology 80
Countries citing papers authored by Rathi N. Pillai
This map shows the geographic impact of Rathi N. Pillai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rathi N. Pillai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rathi N. Pillai more than expected).
Fields of papers citing papers by Rathi N. Pillai
This network shows the impact of papers produced by Rathi N. Pillai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rathi N. Pillai. The network helps show where Rathi N. Pillai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rathi N. Pillai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | 2020 | 11 | |
| 3 | 2019 | 17 | |
| 4 | 2019 | 13 | |
| 5 | 2019 | 60 | |
| 6 | 2018 | 40 | |
| 7 | Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependentbreakdown → | 2017 | 724 |
| 8 | 2017 | 1 | |
| 9 | 2017 | 9 | |
| 10 | 2017 | 8 | |
| 11 | 2017 | 7 | |
| 12 | 2017 | 12 | |
| 13 | 2016 | 91 | |
| 14 | 2016 | 73 | |
| 15 | Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trialbreakdown → | 2016 | 511 |
| 16 | 2016 | 66 | |
| 17 | 2015 | 25 | |
| 18 | 2014 | 54 | |
| 19 | 2014 | 21 | |
| 20 | 2013 | 22 |
About Rathi N. Pillai
Rathi N. Pillai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 87 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (42 papers), Lung Cancer Research Studies (29 papers), Lung Cancer Diagnosis and Treatment (26 papers), Cancer Immunotherapy and Biomarkers (24 papers), CAR-T cell therapy research (7 papers), Cancer Genomics and Diagnostics (6 papers), Neuroendocrine Tumor Research Advances (6 papers) and Head and Neck Cancer Studies (6 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (1.5k citations) and Pulmonary and Respiratory Medicine (1.5k citations). Rathi N. Pillai has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Suresh S. Ramalingam, Taofeek K. Owonikoko, Alice O. Kamphorst, Rafi Ahmed, Fadlo R. Khuri, Madhusmita Behera, Gabriel Sica, Koichi Araki, Shu Yang and Tahseen H. Nasti. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.